Difference between revisions of "Prednisone (Sterapred)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Hodgkin lymphoma" to "Classical Hodgkin lymphoma") |
m |
||
| Line 57: | Line 57: | ||
*[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisone-patient-drug-information Prednisone (Sterapred) patient drug information (UpToDate)]</ref> | ||
| + | ==History of changes in EMA indication== | ||
| + | *1955-05-18: EURD | ||
==Also known as== | ==Also known as== | ||
*'''Generic names:''' pred | *'''Generic names:''' pred | ||
| Line 210: | Line 212: | ||
[[Category:FDA approved in 1955]] | [[Category:FDA approved in 1955]] | ||
| + | [[Category:EMA approved in 1955]] | ||
[[Category:WHO Essential Cancer Medicine]] | [[Category:WHO Essential Cancer Medicine]] | ||
Revision as of 02:09, 14 June 2023
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is established (work in progress)
- B-cell acute lymphoblastic leukemia
- Classical Hodgkin lymphoma
- Langerhans cell histiocytosis
- Multiple myeloma
- Non-Hodgkin lymphoma
- Adult T-cell leukemia-lymphoma
- Anaplastic large cell lymphoma
- Burkitt lymphoma
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- HIV-associated lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Non-Hodgkin lymphoma, pediatric
- Peripheral T-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Waldenström macroglobulinemia
- Prostate cancer
Diseases for which it is used
- Acquired coagulopathy
- B-cell lymphoma of mucosa-associated lymphoid tissue
- Chronic lymphocytic leukemia
- Erdheim-Chester disease
- High-grade glioma, pediatric
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Immune thrombocytopenia (ITP)
- Large granular lymphocytic leukemia
- Mediastinal gray-zone lymphoma
- Myelofibrosis
- Post-transplant lymphoproliferative disorder
- Smoldering multiple myeloma
- T-cell acute lymphoblastic leukemia
- Thymoma
- Transformed lymphoma
Diseases for which it was used
Patient drug information
- Prednisone (Sterapred) patient drug information (Chemocare)[3]
- Prednisone (Sterapred) patient drug information (UpToDate)[4]
History of changes in EMA indication
- 1955-05-18: EURD
Also known as
- Generic names: pred
- Brand names:
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| Artinizona | Artrizona | Becortem | Bersen | Colisone | Cortancyl | Corticorten | Cortigen |
| Cortiol | Cortiprex | Cutason | Dacortin | Decortancyl | Decortin | Decortisyl | Dehydrocortison |
| Delcortin | Dellacorta | Delta-Cortisone | Delta Cortelan | Deltacortene | Deltacortone | Deltason | Deltasone |
| Deltisona | Dispersona | Drazone | Econosone | Ednaprom | Encorton | Erlanison | Flamacorten |
| Hostacortin | Ifison | Isolone | Lisacort | ME Korti | Meticorten | Nisocortec | Nisona |
| Nisone | Nizon | Nosipren | Novoprednisone | Orasone | Panafcort | Panasol-S | Pehacort |
| Pharmapred | Precortil | Predcort | Predeltin | Predicor | Predicorten | Predinis | Preditec |
| Prednax | Prednicap | Prednicen-M | Prednilonga-Retard | Predniment | Prednison | Prednisona | Prednisonum |
| Prednitone | Predson | Predsone | Predval | Procion | Prolix | Pronison | Pulmison |
| Rayos | Rectodelt | Senterlic | Sone | Steerometz | Sterapred | Trolic | Ultracorten |
| Vitazon | Winpred | ||||||
References
Categories:
- Drugs
- Oral medications
- Immunosuppressants
- Steroids
- Adult T-cell leukemia-lymphoma medications
- Anaplastic large cell lymphoma medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Chronic lymphocytic leukemia medications
- Acquired coagulopathy medications
- Diffuse large B-cell lymphoma medications
- Erdheim-Chester disease medications
- Follicular lymphoma medications
- HIV-associated lymphoma medications
- Classical Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Immune thrombocytopenia medications
- Langerhans cell histiocytosis medications
- Large granular lymphocytic leukemia medications
- MALT lymphoma medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Mediastinal gray-zone lymphoma medications
- Multiple myeloma medications
- Myelodysplastic syndrome medications
- Myelofibrosis medications
- Peripheral T-cell lymphoma medications
- Post-transplant lymphoproliferative disorder medications
- Primary mediastinal B-cell lymphoma medications
- Prostate cancer medications
- Smoldering multiple myeloma medications
- T-cell acute lymphoblastic leukemia medications
- Thymoma medications
- Transformed lymphoma medications
- Waldenström macroglobulinemia medications
- Breast cancer medications (historic)
- Chronic myeloid leukemia medications (historic)
- Light-chain (AL) amyloidosis medications (historic)
- Medulloblastoma medications (historic)
- FDA approved in 1955
- EMA approved in 1955
- WHO Essential Cancer Medicine